Urology · New Hyde Park, NY
NPI
1780636696
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
450 Lakeville Rd, Suite M41
New Hyde Park, NY, 11042
Phone (516) 734-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$172K
2,731 services
Medicare patients, 2024
711
Average age 76
Drug cost, 2024
$331K
8,835 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Y Chan was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 803 times for 578 patients. In total David Y Chan billed 2,731 services in 53 codes, and Medicare paid $172K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 803 | 578 | $13.60 | $11K |
| 99214 Office E&M - Established | Office | 646 | 459 | $108.71 | $70K |
| 51798 Ultrasound - Nonspecific | Office | 189 | 168 | $10.41 | $1,968 |
| 99213 Office E&M - Established | Office | 172 | 152 | $66.90 | $12K |
| 99204 Office E&M - New | Office | 118 | 118 | $133.50 | $16K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 108 | 11 | $141.12 | $15K |
| 52000 Cystourethroscopy | Facility | 57 | 50 | $56.95 | $3,246 |
| 76775 Ultrasound - Abdomen and Pelvis | Facility | 55 | 48 | $21.15 | $1,163 |
| 51702 Other Organ Systems | Facility | 50 | 20 | $21.68 | $1,084 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 44 | 42 | $51.16 | $2,251 |
| 51700 Other Organ Systems | Facility | 37 | 21 | $27.83 | $1,030 |
| 99231 Hospital E&M - Subsequent | Facility | 35 | 24 | $44.85 | $1,570 |
| 55700 Other Organ Systems | Facility | 22 | 22 | $114.67 | $2,523 |
| 52000 Cystourethroscopy | Office | 21 | 17 | $200.30 | $4,206 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 21 | 19 | $14.21 | $298 |
By year: 2022 $179K for 1,912 services; 2023 $170K for 1,954 services; 2024 $172K for 2,731 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Y Chan prescribed most often to Medicare patients was Tamsulosin Hcl, with 3,671 prescriptions and refills. In total David Y Chan wrote 8,835 Medicare prescriptions that cost $331K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 3,671 | 8,114 | 1,101 | $51K |
| Finasteride Generic | 2,505 | 5,864 | 729 | $23K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 846 | 1,522 | 217 | $11K |
| Myrbetriq Mirabegron | 268 | 380 | 61 | $173K |
| Trospium Chloride Generic | 193 | 293 | 75 | $5,982 |
| Doxazosin Mesylate Generic | 182 | 407 | 48 | $2,020 |
| Methenamine Hippurate Generic | 147 | 341 | 48 | $14K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 114 | 256 | 33 | $2,003 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 100 | 102 | 43 | $1,851 |
| Dutasteride Generic | 97 | 187 | 24 | $2,687 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 78 | 78 | 63 | $400 |
| Solifenacin Succinate Generic | 55 | 84 | 13 | $1,479 |
| Potassium Citrate Er Potassium Citrate | 50 | 81 | 14 | $2,872 |
| Cephalexin Generic | 44 | 44 | 39 | $740 |
| Terazosin Hcl Generic | 41 | 95 | 11 | $546 |
Brand drugs: - claims; generic drugs: 8,485 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to David Y Chan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.